CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.006
https://www.valueinhealthjournal.com/article/S1098-3015(12)01719-6/fulltext
Title :
CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01719-6&doi=10.1016/j.jval.2012.08.006
First page :
A602
Section Title :
Cost-Effectiveness Studies
Open access? :
No
Section Order :
1570